SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VAXGEN INC. (VXGN)- The IPO
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GPSite who wrote (31)7/12/1999 2:00:00 AM
From: Manfred Sondermann  Read Replies (2) of 55
 
>VaxGen will have the technology, the mechanics of production, the
>patents, and the backing of Genentech.

As far as I read in the prospectus, Genentech is the owner of
the patents. So if everyone will work someday one a prototype
of AIDSVAX, Genentech gets the licensing fees.

Also Genentech has all the options to produce the vaccine.
VXGN does not have the capabilities for that.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News